Tag: #glp1

Lilly’s daily GLP-1 pill beats Novo’s oral semaglutide in diabetes trial, but side effects drive more dropouts

A Phase 3 head-to-head study finds Lilly’s orforglipron lowered A1c and weight more than Rybelsus, with higher quit rates.

#diabetes, #glp1, #weightloss, #pharma, #clinicaltrials

FDA-Approved Wegovy Pill Rolls Out Nationwide, Offering Daily Alternative to Weekly Injections

Novo Nordisk says its once-daily Wegovy tablet is now widely available in the U.S., with lower self-pay prices but strict dosing rules and coverage gaps.

#wegovy, #glp1, #obesity, #cardiovascular, #fda